Phase II randomized study of nemorubicin hydrochloride (PNU-152243A) or doxorubicin administered in adult patients with unresectable hepatocellular carcinoma

Registry ID

EUCTR2006-000798-31

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Nerviano Medical Sciences S.r.l.

Start date

2007-03-02

Completion date

2007-05-16

Last update

2026-08-16

Conditions

• Unresectable hepatocellular carcinoma
• Hepatocellular Carcinoma

Summary

Evaluation of the survival rate at 7 months

Locations

• , , Germany
• , , Italy

Related clinical trials

• First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
• the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma
• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
• STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
• A Study of MGC026 in Participants With Advanced Solid Tumors
• HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

View on source registry